Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 December 1994 | Volume 121 Issue 11 | Pages 877-885
Objective: To characterize the clinical and laboratory features of primary aldosteronism and to evaluate which diagnostic tests can discriminate surgically curable forms of this syndrome.
Design: Retrospective analysis of the following data from 82 patients with primary aldosteronism: blood pressure, serum electrolytes, urinary aldosterone and electrolytes, computed tomographic scans, plasma renin and aldosterone before and during upright posture, atrial natriuretic peptide, and adrenal vein aldosterone and cortisol. Clinical outcomes assessed after treatment included blood pressure, serum electrolytes, and plasma renin activity.
Results: Drug therapy was discontinued before diagnostic tests were done in 56 of 82 patients (34 with adenomas and 22 with hyperplasia). Compared with patients with hyperplasia, those with adenomas had higher systolic (184 mm Hg and 161 mm Hg, respectively; P < 0.001) and diastolic blood pressures (112 mm Hg and 105 mm Hg; P = 0.03), lower serum potassium levels (3.0 mmol/L and 3.5 mmol/L; P < 0.001), and higher serum CO2 (P = 0.001), atrial natriuretic peptide (P = 0.008), and urinary 18-methyl oxygenated cortisol metabolite levels (P = 0.02). In patients with adenomas, aldosterone secretion lateralized to one adrenal gland and did not increase during the postural stimulation test; preoperative urinary aldosterone levels were correlated with diastolic pressures (r = 0.58; P = 0.001). Hypertension was "cured" postoperatively in approximately 35% of patients with adenomas and those with hyperplasia (P > 0.2) but was "improved" more frequently in those with adenomas (P = 0.002). Cured patients from both groups were younger than those not cured (mean ages, 43 years and 54 years, respectively; P = 0.002) and had lower preoperative mean plasma renin activity (0.17 ng/mL per hour and 0.50 ng/mL per hour; P < 0.001). All patients with adenomas in whom aldosterone secretion lateralized were either cured or improved.
Conclusion: Of the 51 patients with primary aldosteronism who had adrenalectomy (43 patients with adenomas and 8 with hyperplasia), those most likely to be cured were younger and had lower plasma renin activity. In patients with adenomas who were cured or improved, aldosterone secretion was more likely to lateralize. Tests that distinguished adenomas from adrenal hyperplasia included the postural stimulation test, urinary excretion rates of 18-oxocortisol and 18-hydroxycortisol, and adrenal vein sampling.
Author and Article Information
From The New York Hospital-Cornell Medical Center, New York, New York and the Veterans Affairs Medical Center, Bronx, New York.
CLINICAL REVIEW
Diagnosis and Treatment of Primary Hyperaldosteronism
![]()
Requests for Reprints: Jon D. Blumenfeld, MD, The Cardiovascular Center, The New York Hospital-Cornell University Medical Center, 520 East 70th Street, Starr 4, New York, NY 10021.
Grant Support: In part by Public Health Research Grant RR00047 from the General Clinical Research Centers Program of the Division of Research Resources; by Hypertension SCOR HL 18323, National Institutes of Health; by the Frederick J and Theresa Dow Wallace Fund of the New York Community Trust; and by a grant from the Wolk Heart Foundation. Dr. Blumenfeld is the recipient of a Clinical Associate Physician Grant from the General Clinical Research Centers Program.
This article has been cited by other articles:
![]() |
A. Karagiannis, K. Tziomalos, A. I Kakafika, V. G Athyros, F. Harsoulis, and D. P Mikhailidis Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas Endocr. Relat. Cancer, September 1, 2008; 15(3): 693 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Funder, R. M. Carey, C. Fardella, C. E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., and V. M. Montori Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3266 - 3281. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Rayner Primary aldosteronism and aldosterone-associated hypertension J. Clin. Pathol., July 1, 2008; 61(7): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Davies, C. Hu, N. A. Guagliardo, N. Sen, X. Chen, E. M. Talley, R. M. Carey, D. A. Bayliss, and P. Q. Barrett TASK channel deletion in mice causes primary hyperaldosteronism PNAS, February 12, 2008; 105(6): 2203 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.C. Wu, S.C. Chueh, H.W. Chang, W.C. Lin, K.L. Liu, H.Y. Li, Y.H. Lin, K.D. Wu, and B.S. Hsieh Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia QJM, January 1, 2008; 101(1): 13 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, et al. Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma Hypertension, August 1, 2007; 50(2): 424 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, and L. A. Sechi Relationships of Plasma Renin Levels with Renal Function in Patients with Primary Aldosteronism Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, and A. Chapman Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension Diabetes Care, July 1, 2007; 30(7): 1699 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Daunt Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful RadioGraphics, October 1, 2005; 25(suppl_1): S143 - S158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ribstein, G. Du Cailar, P. Fesler, and A. Mimran Relative Glomerular Hyperfiltration in Primary Aldosteronism J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1320 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-F. Plouin, L. Amar, and G. Chatellier Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension Nephrol. Dial. Transplant., April 1, 2004; 19(4): 774 - 777. [Full Text] [PDF] |
||||
![]() |
W. F. Young Jr. Minireview: Primary Aldosteronism--Changing Concepts in Diagnosis and Treatment Endocrinology, June 1, 2003; 144(6): 2208 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Young Jr, A. M. Sawka, and J. A. van Heerden Adrenalectomy for Primary Aldosteronism Ann Intern Med, January 21, 2003; 138(2): 158 - 159. [Full Text] [PDF] |
||||
![]() |
D. G. Martinez Adrenalectomy for Primary Aldosteronism Ann Intern Med, January 21, 2003; 138(2): 157 - 158. [Full Text] [PDF] |
||||
![]() |
O. L. Castro, X. Yu, and D. C. Kem Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism Hypertension, April 1, 2002; 39(4): 935 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hirohara, K. Nomura, T. Okamoto, M. Ujihara, and K. Takano Performance of the Basal Aldosterone to Renin Ratio and of the Renin Stimulation Test by Furosemide and Upright Posture in Screening for Aldosterone-Producing Adenoma in Low Renin Hypertensives J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4292 - 4298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sawka, W. F. Young Jr., G. B. Thompson, C. S. Grant, D. R. Farley, C. Leibson, and J. A. van Heerden Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery Ann Intern Med, August 21, 2001; 135(4): 258 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Magill, H. Raff, J. L. Shaker, R. C. Brickner, T. E. Knechtges, M. E. Kehoe, and J. W. Findling Comparison of Adrenal Vein Sampling and Computed Tomography in the Differentiation of Primary Aldosteronism J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1066 - 1071. [Abstract] [Full Text] |
||||
![]() |
G. P. Rossi, A. Sacchetto, M. Chiesura-Corona, R. De Toni, M. Gallina, G. P. Feltrin, and A. C. Pessina Identification of the Etiology of Primary Aldosteronism with Adrenal Vein Sampling in Patients with Equivocal Computed Tomography and Magnetic Resonance Findings: Results in 104 Consecutive Cases J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1083 - 1090. [Abstract] [Full Text] |
||||
![]() |
C. E. Fardella, L. Mosso, C. Gómez-Sánchez, P. Cortés, J. Soto, L. Gómez, M. Pinto, A. Huete, E. Oestreicher, A. Foradori, et al. Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1863 - 1867. [Abstract] [Full Text] |
||||
![]() |
R. P. Ghose, P. M. Hall, and E. L. Bravo Medical Management of Aldosterone-Producing Adenomas Ann Intern Med, April 4, 2000; 132(7): 594 - 594. [Full Text] [PDF] |
||||
![]() |
J. M. Calvo-Romero and J. L. Ramos-Salado Recurrence of adrenal aldosterone-producing adenoma Postgrad. Med. J., March 1, 2000; 76(893): 160 - 161. [Abstract] [Full Text] |
||||
![]() |
A. M. Safi, T. Kwan, E. Afflu, M. Alam, J. E. Anderson, and L. T. Clark Coronary Artery Aneurysms, Aortic Dissection, and Hypertension Secondary to Primary Aldosteronism: A Rare Triad: A Case Report Angiology, June 1, 1999; 50(6): 503 - 508. [Abstract] [PDF] |
||||
![]() |
W. T. Shen, R. C. Lim, A. E. Siperstein, O. H. Clark, W. P. Schecter, T. K. Hunt, J. K. Horn, and Q.-Y. Duh Laparoscopic vs Open Adrenalectomy for the Treatment of Primary Hyperaldosteronism Arch Surg, June 1, 1999; 134(6): 628 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Bornstein, C. A. Stratakis, and G. P. Chrousos Adrenocortical Tumors: Recent Advances in Basic Concepts and Clinical Management Ann Intern Med, May 4, 1999; 130(9): 759 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ganguly Primary Aldosteronism N. Engl. J. Med., December 17, 1998; 339(25): 1828 - 1834. [Full Text] [PDF] |
||||
![]() |
G. A. Mansoor and W. B. White Circadian Blood Pressure Variation in Hypertensive Patients With Primary Hyperaldosteronism Hypertension, March 1, 1998; 31(3): 843 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-F. Plouin, G. Chatellier, I. Fofol, and P. Corvol Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation Hypertension, May 1, 1997; 29(5): 1133 - 1139. [Abstract] [Full Text] |
||||